DD210217A5 - Verfahren zur herstellung stabiler plurilamellarer blaeschen - Google Patents

Verfahren zur herstellung stabiler plurilamellarer blaeschen Download PDF

Info

Publication number
DD210217A5
DD210217A5 DD83249304A DD24930483A DD210217A5 DD 210217 A5 DD210217 A5 DD 210217A5 DD 83249304 A DD83249304 A DD 83249304A DD 24930483 A DD24930483 A DD 24930483A DD 210217 A5 DD210217 A5 DD 210217A5
Authority
DD
German Democratic Republic
Prior art keywords
splb
treatment
item
compounds
animals
Prior art date
Application number
DD83249304A
Other languages
German (de)
English (en)
Inventor
Robert P Lenk
Michael W Fountain
Andrew S Janoff
Marc J Ostro
Micrea C Popescu
Original Assignee
Liposome Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/476,496 external-priority patent/US4522803A/en
Application filed by Liposome Corp filed Critical Liposome Corp
Publication of DD210217A5 publication Critical patent/DD210217A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD83249304A 1982-03-29 1983-03-29 Verfahren zur herstellung stabiler plurilamellarer blaeschen DD210217A5 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US36299482A 1982-03-29 1982-03-29
US36299582A 1982-03-29 1982-03-29
US41146682A 1982-08-25 1982-08-25
US44724782A 1982-12-06 1982-12-06
US46390083A 1983-02-04 1983-02-04
US06/476,496 US4522803A (en) 1983-02-04 1983-03-24 Stable plurilamellar vesicles, their preparation and use

Publications (1)

Publication Number Publication Date
DD210217A5 true DD210217A5 (de) 1984-06-06

Family

ID=27559847

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83249304A DD210217A5 (de) 1982-03-29 1983-03-29 Verfahren zur herstellung stabiler plurilamellarer blaeschen

Country Status (14)

Country Link
EP (1) EP0092453B1 (da)
AU (1) AU564876B2 (da)
DD (1) DD210217A5 (da)
DE (1) DE3373273D1 (da)
DK (1) DK163105C (da)
FI (1) FI83161C (da)
GR (1) GR78163B (da)
HK (1) HK96190A (da)
IE (1) IE54706B1 (da)
IL (1) IL68250A (da)
NZ (1) NZ203746A (da)
PT (1) PT76476B (da)
SG (1) SG13489G (da)
WO (1) WO1983003383A1 (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008005673A1 (de) * 2008-01-23 2009-08-20 Universität Augsburg Bläschen, sowie Verfahren zur Herstellung und Manipulation von Bläschen

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030453A (en) * 1983-03-24 1991-07-09 The Liposome Company, Inc. Stable plurilamellar vesicles
DE3486459D1 (de) * 1983-09-26 1997-12-11 Udo Dr Med Ehrenfeld Mittel und Erzeugnis für die Diagnose und Therapie von Tumoren sowie zur Behandlung von Schwächen der zelligen und humoralen Immunabwehr
DE3336583A1 (de) * 1983-09-26 1985-04-25 Udo Dr. 8400 Regensburg Ehrenfeld Erzeugnis zur diagnose und therapie von malignen tumoren
DE3585967D1 (de) * 1984-03-08 1992-06-11 Phares Pharma Holland Liposombildende zusammensetzung.
FR2562421B1 (fr) * 1984-04-09 1989-02-17 Sandoz Sa Perfectionnements a la therapie par l'interleukine
AU591466B2 (en) * 1984-10-22 1989-12-07 Vestar, Inc. Method of delivering micellular particles encapsulating imaging and chemotherapeutic agents to tumors in a body
EP0179660A3 (en) * 1984-10-26 1987-08-12 The Liposome Company, Inc. Multilayered vesicles prepared by reverse-phase evaporation
BE902199A (fr) * 1984-10-29 1985-07-31 Vira Tek Inc Procede de traitement medical de maladies virales utilisant le 1-beta-d-ribofurannosyl-1, 2,4-triazole-3-carboxamide.
US5409704A (en) * 1985-06-26 1995-04-25 The Liposome Company, Inc. Liposomes comprising aminoglycoside phosphates and methods of production and use
JP2579625B2 (ja) * 1985-07-05 1997-02-05 ザ リポソ−ム カンパニ−，インコ−ポレイテツド 改良された取り込み効率を有するマルチラメラリポソ−ム
IL79114A (en) * 1985-08-07 1990-09-17 Allergan Pharma Method and composition for making liposomes
US4983397A (en) * 1985-08-19 1991-01-08 Board Of Regents, University Of Texas System Pharmaceutical compositions consisting of acylated phospholipids
CA1308020C (en) * 1986-03-26 1992-09-29 Ian Gibbons Liquid single reagent for assays
US5068198A (en) * 1986-03-26 1991-11-26 Syntex (U.S.A.) Inc. Liquid single reagent for assays involving confining gels
JPH0751496B2 (ja) * 1986-04-02 1995-06-05 武田薬品工業株式会社 リポソ−ムの製造法
EP0249561B1 (en) * 1986-06-12 1992-05-13 The Liposome Company, Inc. Compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
PT85537B (pt) * 1986-08-18 1990-06-29 Univ Texas Processo para a preparacao de um sistema de administracao farmaceutica contendo peptidos apresentando quimiotaxia
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
US4914088A (en) * 1987-04-02 1990-04-03 Thomas Glonek Dry eye treatment solution and method
FR2648462B1 (fr) * 1989-06-15 1994-01-28 Oreal Procede pour ameliorer l'efficacite therapeutique de corticosteroides liposolubles et composition pour la mise en oeuvre de ce procede
US10307491B2 (en) 2015-01-30 2019-06-04 The Regents Of The University Of Michigan Liposomal particles comprising biological molecules and uses thereof
AU2016238290B9 (en) 2015-03-25 2019-06-13 The Regents Of The University Of Michigan Compositions and methods for delivery of biomacromolecule agents
WO2017127503A2 (en) * 2016-01-19 2017-07-27 The Regents Of The University Of Michigan Vesicle-encapsulated socs
JP2022510735A (ja) 2018-12-10 2022-01-27 エテルナティアー インコーポレイテッド 長続きする眼の潤滑をもたらす眼用配合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115544A (en) * 1976-08-18 1978-09-19 Alza Corporation Ocular system made of bioerodible esters having linear ether
CH624011A5 (da) * 1977-08-05 1981-07-15 Battelle Memorial Institute
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008005673A1 (de) * 2008-01-23 2009-08-20 Universität Augsburg Bläschen, sowie Verfahren zur Herstellung und Manipulation von Bläschen

Also Published As

Publication number Publication date
PT76476B (en) 1985-12-10
NZ203746A (en) 1987-03-06
DE3373273D1 (de) 1987-10-08
IE830690L (en) 1983-09-29
AU564876B2 (en) 1987-08-27
EP0092453B1 (en) 1987-09-02
FI83161C (fi) 1991-06-10
WO1983003383A1 (en) 1983-10-13
FI83161B (fi) 1991-02-28
EP0092453A3 (en) 1983-12-07
IL68250A0 (en) 1983-06-15
DK544883A (da) 1983-11-28
FI834364A0 (fi) 1983-11-29
DK544883D0 (da) 1983-11-28
AU1519683A (en) 1983-10-24
FI834364A (fi) 1983-11-29
PT76476A (en) 1983-04-01
HK96190A (en) 1990-11-30
SG13489G (en) 1989-07-07
EP0092453A2 (en) 1983-10-26
IE54706B1 (en) 1990-01-17
IL68250A (en) 1990-02-09
GR78163B (da) 1984-09-26
DK163105B (da) 1992-01-20
DK163105C (da) 1992-06-15

Similar Documents

Publication Publication Date Title
DD210217A5 (de) Verfahren zur herstellung stabiler plurilamellarer blaeschen
DE60035669T2 (de) Neue in einem hydrogel isolierte cochleat-formulierungen, verfahren zu deren herstellung und deren verwendung zur verabreichung von biologisch aktiven molekülen
DE68901955T2 (de) Insbesondere zum tragen von biologisch aktiven molekuelen geeignetes teilchenfoermiges vektorsystem und verfahren zu seiner herstellung.
US4522803A (en) Stable plurilamellar vesicles, their preparation and use
DE69837348T2 (de) Verfahren zur inaktivierung von bakterien mit einbegriff von bakteriensporen
DE69211691T2 (de) Pharmazeutische formulierung und pharmazeutisches verfahren
DE69304685T2 (de) Verfahren zur behandlung infizierter gewebe
DE3587639T3 (de) Entwässerte liposome.
DE3650302T2 (de) Auf alpha-tocopherol basierte bläschen.
DE3880397T2 (de) Amphotericin b/cholesterolsulfat-zusammensetzung und -verfahren.
DE69027112T2 (de) Impfstoffzusammensetzung
DE2907303A1 (de) Verfahren zur einkapselung biologisch aktiver substanzen
DE68927669T2 (de) Verfahren zur herstellung von in lösungsmitteln verdünnbaren mikroträgern
JPS60502205A (ja) 単一相中で調製された脂質小胞類
DE3141223A1 (de) "oral verabreichbare arzneimittel zur therapie und prophylaxe von haemophilie a"
DE60032908T2 (de) Zielgerichtete fiberlose radiative effektoren
DE602004011982T2 (de) Verfahren zur Beladung von therapeutischen Mitteln in vorgeformte Liposomen und das dabei erhaltene Produkt
DD297331A5 (de) Verfahren zur herstellung eines impfstoffes
DE69829963T2 (de) Zusammensetzungen und verfahren zur behinderung der entladung von nematokyste
DE68916956T2 (de) Aktives mittel: lipid-komplex mit hohem verhältnis.
EP0819434A1 (de) Verwendung von PHMB zur Behandlung von Tumorerkrankungen
DE69535059T2 (de) Borrelia burgdorferi bacterin
CH668005A5 (de) Fusogene liposome und verfahren zu deren herstellung.
DE4122744C2 (de) Wäßriges Liposomensystem und Verfahren zu seiner Herstellung
EP0788797A1 (de) Verwendung von PHMB zur Behandlung von durch sich intrazellulär vermehrende Erreger verursachten Infektionen